FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
25/06/2026
Voltar para busca
Dado oficial do USPTO
PATHOQ
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
25/06/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42
Data de depósito
30/09/2024
Data de registro
18/11/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/11/2025
Última transação
25/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
CN
Examinador
SUAREZ, MARIA VICTORIA
Unidade examinadora
O60
Localização atual
TMO LAW OFFICE 133
Descrição da marca
The mark consists of the letters "PATHOQ" in plain block text, with the first letter "P" and the last letter "Q" in capital letters and the remaining letters in lower case.
Titulares e representantes
Titulares
Wuhan ABclonal Biotechnology Co., Ltd.
Representantes
Kevin L. Russell CHERNOFF VILHAUER LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Enzyme preparations for industrial purposes; chemical preparations for scientific purposesother than for medical or veterinary use; chemical preparations for analyses in laboratoriesother than for medical or veterinary purposes; diagnostic preparationsother than for medical or veterinary purposes; biological preparationsother than for medical or veterinary purposesbiological preparations for use in industry and sciencebiological preparation for use in cell cultures other than for medical or veterinary use; bacteriological preparationsbacteriological culture mediums other than for medical and veterinary use; biological tissue culturesother than for medical or veterinary purposes; preparations of microorganismsother than for medical and veterinary use; biochemical catalysts; reagent paperother than for medical or veterinary purposes
Classe 5
Reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; cultures of microorganisms for medical or veterinary use; bacteriological preparations for medical and veterinary use; bacterial preparations for medical and veterinary use; biological preparations for medical purposesbiological preparations for the treatment of cancerbiological preparations for use in cell cultures for medical purposesbiological preparations for the treatment of immune system related diseases and disorders; chemical preparations for medical purposeschemical preparations for the treatment of cancer; chemical preparations for medical purposeschemical preparations for sanitary use; chemical preparations for medical purposeschemical preparations for the diagnosis of tumorsreproductive and immune system related diseases and disorders; enzyme preparations for medical purposes; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes
Classe 42
Research and development of new products for others; technological research in the field of DNA sequencing; technological research in the field of cell engineering technology; scientific and technological servicestechnological research on tumors and tumor microenvironmentimmunologysignaling pathwaysmolecular biologycell biology in the life science research field; chemical analysis; chemistry servicesresearch and development in the field of chemistry; chemical research; bacteriological research; biological research; conducting clinical trials for others; medical research; Medical research laboratories
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/06/2026
FIMP
FINAL DISPOSITION PROCESSED
05/06/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
14/04/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/04/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/04/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
18/02/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
18/11/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
18/11/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/09/2025
PUBO
PUBLISHED FOR OPPOSITION
30/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
24/09/2025
RFNP
REFUSAL PROCESSED BY IB
29/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/08/2025
ATRV
ATTORNEY REVIEW COMPLETED
29/08/2025
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
29/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/08/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/08/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
26/08/2025
CNRT
NON-FINAL ACTION WRITTEN
31/07/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/06/2025
DOCK
ASSIGNED TO EXAMINER
23/06/2025
RFNT
REFUSAL PROCESSED BY IB
31/05/2025
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
23/05/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/05/2025
RFRR
REFUSAL PROCESSED BY MPU
07/05/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/03/2025
CNRT
NON-FINAL ACTION WRITTEN
19/03/2025
DOCK
ASSIGNED TO EXAMINER
19/03/2025
MAFR
APPLICATION FILING RECEIPT MAILED
14/01/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/01/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
13/01/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/01/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PATHOQ ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.